Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
about
Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesDampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replicationGenital HSV-2 infection induces short-term NK cell memoryInterferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsInduction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapyCharacterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus.Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornProphylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virusInnate and adaptive immune responses to herpes simplex virusToll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine.The Roles and Perspectives of Toll-Like Receptors and CD4(+) Helper T Cell Subsets in Acute Viral Encephalitis.Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue.Sensing of viral infection and activation of innate immunity by toll-like receptor 3OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon productionIFN-α subtypes: distinct biological activities in anti-viral therapy.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection.Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) InfectionInterleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissuesOverexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.TANK-binding kinase-1 plays an important role during in vitro and in vivo type I IFN responses to DNA virus infections.A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophagesFSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.Toll-like receptors and genital tract infection.Recent insights into the role of Toll-like receptors in viral infection.Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?The type I interferon response during viral infections: a "SWOT" analysis.Sensing herpes: more than toll.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.Oligodeoxynucleotides inhibit Toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes.Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection.Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity.Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.A critical role for IL-15 in TLR-mediated innate antiviral immunity against genital HSV-2 infection.
P2860
Q27487393-5E60D865-0671-422A-969C-F1E1ECCF948EQ27869764-218528F0-8CBC-4638-9419-413E0F1A8D16Q28481627-EC058346-2AB2-4E36-9195-A6860C1B40E0Q30499869-B44BC6C5-714C-4300-8427-C953B04B5382Q30683907-18CFB2C5-00CB-43FE-A344-FFFF7225A236Q33389846-952149F8-956D-4D2F-B7ED-114419D5B25AQ33710019-30CB54EE-1E38-42E9-A183-798E5A42C5A5Q33725157-D8B589CC-6EF3-48AE-AF0E-83E9CC29ED0EQ33835386-78830B65-ADAB-4049-823B-CB1D34477C3BQ34105712-4E296CDD-DA33-434E-9C19-FC38B04807AEQ35260078-01FA5D27-8CA6-4396-9EE8-C30D27B69B0EQ35779664-A2736B54-EB86-4F8B-A345-23297930E216Q36056898-180228CF-D42E-4FF5-8D9D-05756E23F4B2Q36419852-FFF674A1-7233-4102-BB96-BC924AF827BEQ36422519-CF7050A5-E44C-4850-8D5F-DBCEF723F4CAQ36448944-2CAA1DB3-90F6-4439-B891-EC9B8BAC5994Q36675798-BEFA73A8-45C1-4DA5-BFF7-3EAD77E29070Q36807121-79C80797-0ADA-4A76-8D68-40FCFF8BC678Q36913153-DDBDB409-3065-470E-ABE6-2D9DB80D5F1BQ36978882-9779B311-A448-4C21-AA65-635AB450F647Q36981179-C88F8BB4-2B31-4489-A1D9-B13876D4BF68Q37033141-CF4888DB-FC32-4207-9DB4-05CAA2DAF528Q37033348-9FF32E78-7BFA-446E-83A8-A9D9FA37801FQ37033387-BDA54369-F59F-4E60-A41F-F6BA24307663Q37130854-7CECBB07-F379-4E99-9AE2-528CBDDC0759Q37202989-9A5D5630-CAFA-4D61-8A03-223A84887049Q37428262-6F9D21DD-1B3E-4D09-902F-F359A3BE563FQ37705702-E89CD6F7-BF22-4C79-9AFD-CCE46807D1E4Q37766262-3B0D5B3B-3CCF-42A1-8AA7-766C5DD2FF47Q37827571-F2CE6E6C-559E-409F-88BC-0420370A305BQ37942501-66A3F097-45E8-47F3-9519-18F32CB793D5Q37948677-62F8DFF8-5DCC-41EC-B763-C7EA35A74BE3Q38195597-45F05FE2-7595-4C1A-923A-2C6C42C51D7EQ39171123-554EF9BD-BC2E-4331-8AF4-FF480DCAFE11Q39443382-6D6339FB-8228-43D0-9123-E29FE953C49AQ40027571-1B83E4C5-59EB-42BB-8E79-E84CDD753C6AQ40305813-2A3A7ADD-29AD-40AC-A9DC-1484596C60F3Q41271614-892C3A04-7E02-4B3B-AEFD-22063506A87BQ45392569-8EA5B6EB-3FA6-430A-9CE2-5F4909EE19B2Q45415657-E1233D7A-12AC-4B46-8513-A919374C2471
P2860
Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Induction of innate immunity a ...... th beta interferon production.
@ast
Induction of innate immunity a ...... th beta interferon production.
@en
type
label
Induction of innate immunity a ...... th beta interferon production.
@ast
Induction of innate immunity a ...... th beta interferon production.
@en
prefLabel
Induction of innate immunity a ...... th beta interferon production.
@ast
Induction of innate immunity a ...... th beta interferon production.
@en
P2093
P2860
P356
P1433
P1476
Induction of innate immunity a ...... ith beta interferon production
@en
P2093
Brian Lichty
Navkiran Gill
Philip M Deacon
P2860
P304
P356
10.1128/JVI.01036-06
P407
P577
2006-10-01T00:00:00Z